Zoonotic infections arise from pathogens, including bacteria, viruses, parasites, or fungi, capable of crossing the species barrier between animals and humans. Originating in animals, these infections can be transmitted to humans through direct contact, consumption of contaminated food or water, or exposure in environments where animals and humans interact. Notable examples of zoonotic infections encompass influenza viruses, Ebola virus, Lyme disease, and Salmonella infections. The transmission dynamics of these diseases are influenced by factors such as ecological changes, human behaviors, and the adaptability of pathogens to diverse hosts. Zoonotic infections present considerable public health challenges due to their potential for rapid dissemination and the complexity of predicting and preventing their emergence. Effective management and prevention require surveillance, interdisciplinary collaboration between veterinary and human health professionals, and public awareness initiatives. A comprehensive understanding of the intricate dynamics of zoonotic infections is vital for addressing emerging threats, lessening their impact on human and animal health, and embracing a holistic One Health approach that recognizes the interconnections between human, animal, and environmental health.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy